Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6
Closed -$810 577
2024
Q3
$810 Hold
6
﹤0.01% 489
2024
Q2
$814 Hold
6
﹤0.01% 505
2024
Q1
$775 Hold
6
﹤0.01% 526
2023
Q4
$686 Buy
+6
New +$599 ﹤0.01% 535
2017
Q1
Sell
-45
Closed -$2.23K 554
2016
Q4
$2.23K Buy
+45
New +$2.28K ﹤0.01% 469

Other funds holding XYL

West Paces Advisors's XYL Position: Q4 2024 in Review

West Paces Advisors sold out of Xylem (XYL) in Q4 2024, closing a stake of 6 shares — an estimated $810 sold.

West Paces Advisors first reported a position in XYL in Q4 2016 and held it in 5 quarters. The position peaked at $2.23K in Q4 2016. 1,001 funds tracked by Wall St. Rank hold XYL as of Q4 2024.

  • West Paces Advisors reported no remaining Xylem position as of Q4 2024 after selling out during the quarter.
  • West Paces Advisors sold 6 Xylem shares in Q4 2024, an estimated $810.
  • West Paces Advisors first reported a position in Xylem in Q4 2016 and held it in 5 quarters.
  • West Paces Advisors's Xylem position peaked at $2.23K in Q4 2016.
  • 1,001 funds tracked by Wall St. Rank held Xylem as of Q4 2024.

Based on West Paces Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.